ArticlePloS one2026
A hemorheological perspective on coronary microvascular dysfunction: Association of erythrocyte parameters with angiography-derived coronary microcirculatory resistance.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary microvascular dysfunction (CMD) contributes to myocardial ischemia in patients both without obstructive coronary artery disease (e.g., MINOCA/INOCA) and in those with co-existing epicardial stenosis. While its etiology includes structural and functional causes. hematologic parameters have been linked to cardiovascular outcomes. However, the relationship between red blood cell (RBC) markers and microvascular resistance remains poorly characterized. We aim to evaluate whether RBC parameters are correlated with the angiography-derived index of microcirculatory resistance (angio-IMR).
methodsThis retrospective study evaluated the association between red blood cell (RBC) parameters and angio-IMR in patients with intermediate coronary artery disease (30%-70% stenosis). Data were analyzed from 604 patients, comprising 733 lesions; red blood cell parameters were obtained during hospitalization prior to angiography. Coronary microcirculatory resistance was derived using the AngioPlus mQFR system. Multivariable linear regression models adjusted for confounders. Subgroup analyses assessed effect modification by diabetes status, and sensitivity analyses excluded hematocrit outliers, and analyses stratified by vessel (left anterior descending (LAD), left circumflex (LCx), right coronary artery (RCA)).
resultsHigher RBC, Hct and Hgb were independently associated with elevated angio-IMR after full adjustment (RBC: β = 0.182, P < 0.001; Hct: β = 0.019, P < 0.001; Hgb: β = 0.006, P < 0.001). Results remained robust after excluding Hct outliers (β = 0.020, P < 0.001) and consistent across diabetic (P = 0.007) and non-diabetic subgroups (P = 0.012). The association was significant in non-LAD vessels (Hct: β = 0.022, P < 0.001) but not in LAD lesions (Hct: β = 0.008, P = 0.357).
conclusionElevated RBC parameters are independently associated with increased microcirculatory resistance, particularly in non-LAD vessels. These findings suggest that RBC parameters may serve as clinically relevant markers of microvascular dysfunction, warranting further investigation into their prognostic and therapeutic implications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.